[go: up one dir, main page]

DK0784466T3 - Anvendelse af og præparat indeholdende en formulering mod seksuelt overførte sygdomme - Google Patents

Anvendelse af og præparat indeholdende en formulering mod seksuelt overførte sygdomme

Info

Publication number
DK0784466T3
DK0784466T3 DK95937526T DK95937526T DK0784466T3 DK 0784466 T3 DK0784466 T3 DK 0784466T3 DK 95937526 T DK95937526 T DK 95937526T DK 95937526 T DK95937526 T DK 95937526T DK 0784466 T3 DK0784466 T3 DK 0784466T3
Authority
DK
Denmark
Prior art keywords
stds
formulation
infectant
composition
std
Prior art date
Application number
DK95937526T
Other languages
English (en)
Inventor
William Joseph Bologna
Howard Leslie Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Application granted granted Critical
Publication of DK0784466T3 publication Critical patent/DK0784466T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/14—Topical contraceptives and spermacides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95937526T 1994-10-07 1995-10-06 Anvendelse af og præparat indeholdende en formulering mod seksuelt overførte sygdomme DK0784466T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/319,495 US5667492A (en) 1994-10-07 1994-10-07 Use and composition of an anti-sexually transmitted diseases formulation
PCT/US1995/013424 WO1996010989A1 (en) 1994-10-07 1995-10-06 Use and composition of an anti-sexually transmitted diseases formulation

Publications (1)

Publication Number Publication Date
DK0784466T3 true DK0784466T3 (da) 2002-04-22

Family

ID=23242477

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937526T DK0784466T3 (da) 1994-10-07 1995-10-06 Anvendelse af og præparat indeholdende en formulering mod seksuelt overførte sygdomme

Country Status (24)

Country Link
US (2) US5667492A (da)
EP (1) EP0784466B1 (da)
JP (1) JPH10507178A (da)
KR (1) KR970705976A (da)
AT (1) ATE213623T1 (da)
AU (1) AU704836B2 (da)
BR (1) BR9509280A (da)
CA (1) CA2201872A1 (da)
CO (1) CO4480018A1 (da)
DE (1) DE69525634T2 (da)
DK (1) DK0784466T3 (da)
ES (1) ES2173203T3 (da)
FI (1) FI971440A0 (da)
HU (1) HUT77527A (da)
IL (1) IL115495A0 (da)
MA (1) MA23687A1 (da)
MX (1) MX9504245A (da)
NO (1) NO971491L (da)
NZ (1) NZ295947A (da)
PE (1) PE46996A1 (da)
PT (1) PT784466E (da)
RU (1) RU2157184C2 (da)
WO (1) WO1996010989A1 (da)
ZA (1) ZA958434B (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5942243A (en) * 1996-11-12 1999-08-24 Polytherapeutics, Inc. Mucoadhesive compositions for administration of biologically active agents to animal tissue
KR20010012464A (ko) * 1997-05-12 2001-02-15 세이지 파마슈티칼스, 인크. 화상 치료 및 감염 방지를 위한 국소 분무
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
EP1356806A1 (en) * 1997-09-12 2003-10-29 Columbia Laboratories (Bermuda) Limited A pharmaceutical composition for treating dysmenorrhea and premature labor
US20040234606A1 (en) * 1997-09-12 2004-11-25 Levine Howard L. Localized vaginal delivery without detrimental blood levels
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6939569B1 (en) 1998-06-19 2005-09-06 Oxibio, Inc. Medical device having anti-infective and contraceptive properties
WO1999066900A2 (de) * 1998-06-23 1999-12-29 Notax Holding Gesellschaft Mbh Verwendung von nonoxynol-9 als gleitmittel sowie verfahren zu seiner herstellung
US6159491A (en) * 1999-02-12 2000-12-12 Biovector Technologies, Inc. Prolonged release bioadhesive vaginal gel dosage form
US6818672B1 (en) 1999-10-05 2004-11-16 Columbia Laboratories, Inc. Treating endometriosis or infertility, or improving fertility
US6479045B2 (en) 1999-12-22 2002-11-12 Columbia Laboratories, Inc. Vaginal pH buffering for preventing miscarriage and premature labor, by treating or preventing bacterial vaginosis
AU2001243431B2 (en) 2000-03-07 2006-05-25 Rush University Medical Center Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
EP1363600B1 (en) * 2001-02-15 2008-10-01 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7544348B2 (en) * 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
JP2005519868A (ja) * 2001-10-16 2005-07-07 アバニール・ファーマシューティカルズ ｎ−ドコサノールによるウイルス阻害
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US7709026B2 (en) * 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
RU2200571C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, активный в отношении вирусных и других инфекций, передаваемых половым путем
RU2200572C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, обладающий противоинфекционным действием в отношении инфекций, передаваемых половым путем
RU2200570C1 (ru) * 2002-02-26 2003-03-20 Быков Валерий Алексеевич Комплекс природных соединений растительного происхождения, обладающий сперматоцидным эффектом и активностью в отношении инфекций, передаваемых половым путем
US20070021449A1 (en) * 2003-02-07 2007-01-25 Jan Heeres Pyrimidine derivatives for the prevention of hiv infection
ES2237298B1 (es) * 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
ITMI20031640A1 (it) 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
NZ703203A (en) * 2012-06-13 2016-07-29 Evofem Inc Compositions and methods for enhancing the efficacy of contraceptive microbicides
CN114452298A (zh) 2013-12-19 2022-05-10 伊沃菲姆股份有限公司 使用基于藻酸的抗微生物化合物抑制炎症和疾病的组合物和方法
CN105250280B (zh) * 2014-07-14 2020-03-10 诺维科国际控股股份有限公司 包含辛苯聚醇和喹诺里西啶生物碱化合物或其来源的杀微生物组合物
EP3522879A4 (en) 2016-10-04 2020-06-03 Evofem, Inc. Method of treatment and prevention of bacterial vaginosis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL128902C (da) * 1960-06-06
US4286593A (en) * 1980-05-05 1981-09-01 Place Virgil A Vaginal contraceptive shield
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
EP0501523B1 (en) * 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US5000749A (en) * 1988-10-13 1991-03-19 Leveen Harry H Iodine contraceptive sponge
DE69012955T2 (de) * 1989-10-31 1995-02-09 Columbia Laboratories, Inc., Miami, Fla. Verfahren zur Feuchthaltung von Gewebe und Mittel dazu.
DK0431719T3 (da) * 1989-10-31 1995-02-27 Columbia Lab Inc Vaginalt vævsbefugtende præparat
RU2104034C1 (ru) * 1989-10-31 1998-02-10 Колумбия Лабораториз, Инк. Способ увлажнения эпителиальных клеток, увлажняющая композиция, вагинальная увлажняющая композиция, способ получения увлажняющей композиции
US5380523A (en) * 1993-08-17 1995-01-10 University Of Kentucky Research Foundation High energy coprecipitate of nonoxynol oligomer, PVP and iodine having contraceptive and potent anti-HIV properties

Also Published As

Publication number Publication date
CO4480018A1 (es) 1997-07-09
NO971491D0 (no) 1997-04-02
FI971440L (fi) 1997-04-07
RU2157184C2 (ru) 2000-10-10
DE69525634T2 (de) 2002-08-29
ZA958434B (en) 1996-05-08
PE46996A1 (es) 1996-11-23
NZ295947A (en) 1999-02-25
HUT77527A (hu) 1998-05-28
ES2173203T3 (es) 2002-10-16
EP0784466A1 (en) 1997-07-23
CA2201872A1 (en) 1996-04-18
US20010006667A1 (en) 2001-07-05
MX9504245A (es) 1997-01-31
JPH10507178A (ja) 1998-07-14
US5667492A (en) 1997-09-16
BR9509280A (pt) 1997-11-18
FI971440A7 (fi) 1997-04-07
PT784466E (pt) 2002-06-28
IL115495A0 (en) 1996-01-19
DE69525634D1 (de) 2002-04-04
AU3961295A (en) 1996-05-02
MA23687A1 (fr) 1996-07-01
EP0784466B1 (en) 2002-02-27
NO971491L (no) 1997-06-09
KR970705976A (ko) 1997-11-03
AU704836B2 (en) 1999-05-06
ATE213623T1 (de) 2002-03-15
FI971440A0 (fi) 1997-04-07
WO1996010989A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
DK0784466T3 (da) Anvendelse af og præparat indeholdende en formulering mod seksuelt overførte sygdomme
US5071644A (en) Topical drug delivery with thermo-irreversible gels
IT1251151B (it) Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US5387611A (en) Use of butylurea, nonoxynol-9 and benzalkonium chloride as anti-bacterial, anti-viral contraceptive agents
JPS62234017A (ja) 膣用医薬組成物
JP4416844B2 (ja) 架橋ポリビニルピロリドン−ヨウ素複合物及びその製造方法
CN102858374B (zh) 热胶凝麻醉剂组合物
ES2075249T3 (es) Dispositivo adhesivo para la administracion transdermica de un agente activo.
CA2111932A1 (en) Quick-Drying Gel-Type Disinfectant for Hands and Fingers
AR015524A1 (es) FORMULACIoN ESTABLE DE SOLUCIoN DE OXIPLATINO, SU USO PARA LA MANUFACTURA DE UN MEDICAMENTO, PROCESO PARA SU PREPARACIoN, PRODUCTO FARMACÉUTICO QUE LA CONTIENE Y UN MÉTODO PARA ESTABILIZAR UNA SOLUCIoN DE OXALIPLATINO.
JP2004505028A (ja) 粘膜炎、口内炎およびベーチェット症候群などの湿性上皮表面の疼痛性、炎症性および潰瘍性症状の治療のための医薬組成物
ES2105332T3 (es) Polimeros quelantes.
ES2139021T3 (es) Composiciones germicidas de detergente-yodo que tienen un contenido reducido de detergente.
BR9813262A (pt) Terapia de progestina com sangramento controlado
BR0116186A (pt) Sistema de gelificação reversìvel para liberação de droga ocular
MY149482A (en) Vaginal formulation of lidocaine for treating uterine dysrhythmia
DE60127839D1 (de) Pflaster mit 4-biphenylessigsäure
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
DK173716B1 (da) Ikke-farmaceutisk komposition som indeholder en overfladeaktiv forbindelse og en fluorforbindelse
SE9302203D0 (sv) Composition for ophthalmic use
JPS6242922A (ja) ゲル状軟膏
于大雄 et al. One Shot Irrigation of the Bladder with Chlorhexidine for the Prevention of Urinary Tract Infection after Transurethral Operations
SU1827797A3 (ru) Лекарственный препарат для анестезии глаз
YU84300A (sh) Postupak za dobijanje antibiotske masti oksitetraciklina natopljene na sterilnu gazu
JPH04154726A (ja) 潤滑剤